Protection and rescue from 2′,3′-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 191-195

  Fowler, David A ^b   Xie, Meng Yu ^b   Sommadossi, Jean Pierre ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3' AMINO 3' DEOXYTHYMIDINE; HEMIN; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD TOXICITY; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD34; BONE MARROW; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DEOXYURIDINE; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HEMIN; HUMANS; ZIDOVUDINE;

EID: 0030069108     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.191     Document Type: Article

References (36)

1. Abraham, N. G., D. Bicher, U. Niranjan, A. C. Brown, J. D. Lutton, A. Distenfeld, T. Ahmed, and R. D. Levere. 1989. Microenvironmental toxicity of azidotbymidine. partial sparing with hemin. Blood 74:139-144.
2. Abraham, N. G., J. L. Chertkov, R. Staudinger, S. Jiang, J. D. Lutton, I. Argani, R. D. Levere, and A. Kappas. 1993. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1 Exp. Hematol. 21:263-268.
3. Abraham, N. G., R. D. Levere, and J. D. Lutton. 1991. Eclectic mechanisms of heme regulation of hematopoiesis. Int. J Cell Clon 9:185-210
4. Abraham, N. G., A. Mathew, S. Jiang, J. D. Lutton, M. Nishimura, J. L. Chertkox, and R. D. Levere. 1991. Comparison of hemin enhancement of burst-forming units-erythroid clonal efficiency by progenitor cells from normal and HIV-infected patients Acta Haematol. 86:189-193.
5. Allegra, C. J., B. A. Chabner, C. U. Tuazon, D. Ogata-Arakaki, B. Baird, J. C. Drake, J. T. Simmons, E. E. Lack, J. H. Shelhamer, F. Balis, R. Walker, J. A. Kovacs, J. C. Lane, and H. Masur. 1987. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N. Engl J Med 317:978-985.
6. Baum, R. M. 1993 AIDS: scientific progress, but no cure in sight Chem. Eng. News July 5:20-27.
7. Bender, J. G., K. L. Unverzagt, D. E. Walker, W. Lee, D. E. Van Epps, D. H. Smith, C. C. Stewart, and L. Bik To. 1991. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry, Blood 77:2591-2596
8. Capizzi, R. L., R. C. DeConti, J. C. Marsh, and J. R. Bertino. 1970. Methotrexate therapy of head and neck cancer improvement in therapeutic index by the use of leucovorin "rescue " Cancer Res. 30:1782-1788.
9. Chertkov, J. L., S. Jiang, J. D. Lutton, R. D. Levere, and N. G. Abraham. 1991. Hemin stimulation of hemopoiesis in murine long-term bone marrow culture. Exp. Hematol 19:905-909.
10. Cretton, E. M., M.-Y. Xie, R. J. Bevan, N. M. Goudgaon, R. F. Schinazi, and J. P. Sommadossi. 1991 Catabolism of 3́-azido-3́-deoxythyrnidine in hepatocytes and liver microsomes, with evidence of formation of 3′-amino-3′-deoxythymidine, a highly toxic catabolite for human bone marrow cells Mol Pharm. 39:258-266.
11. Debnath, A. K., S. Jiang, N. Strick, K. Lin, P. Haberfield, and A. R. Neurath. 1994. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp 120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 37:1099-1108.
12. Faraj, A., D. A. Fowler, E. G. Bridges, and J. P. Sommadossi. 1994. Effects of 2′,3′-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38:924-930.
13. Flexner, C., C. van der Horst, M. A. Jacobson, W. Powderly, and B. Polsky. 1994. Relationship between plasma concentrations of 3′-deoxy-3′-fluorothymidine (Alovudine) and antiretroviral activity in two concentration-controlled trials. J. Infect. Dis. 170:1394-1403.
14. Gaues, D., P. Barditch, F. Duncauson, R. Falkner, C. Flexner, O. Kuye, G. Nicolau, C. Norden, B. Rae, A. Tonelli, and A. Yacobi. 1992. Population pharmacodynamic modeling of FLT-induced anemia in AIDS/ARC patients. p. 185. In Program and Abstracts of the 93rd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics. Mosby Yearbook, St. Louis.
15. Gopalakrishnan, T. V., and W. F. Anderson. 1979. Mouse erythroleukemia cells. Methods Enzymol. 58:506-511.
16. Hamburger, A. W., and R. B. Chen. 1904 Amelioration of azidothyidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice. Exp. Hematol. 22:348-352.
17. Harrison, J., A. Kappas, R. D. Levere, J. D. Lutton, J. L. Chertkov, S. Jiang, and N. G. Abraham. 1993. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment Blood 82: 3574-3579.
18. Hoffman, L. M., and J. Ross. 1980. The role of heme in the maturation of erythroblasts. The effects of inhibition of pyridoxine metabolism. Blood 55:762-771.
19. Hunt, D. W., R. A. Sorrenti, C. B. Smits, and J. G. Levy. 1993 Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse. Immunopharmacology 26:203-212.
20. Lansdorp, P. M., H. J. Sutherland, and C. J. Eaves. 1990. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J. Exp. Med. 172:363-366.
21. Levere, R. D., Y.-F. Gong, A. Kappas, D. J. Bucher, G. P. Wormser, and N. G. Abraham. 1991. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine. Proc. Natl Acad. Sci USA 88:1756-1759.
22. Loewy, G., P. Cook, T. Ahmed, J. D. Lutton, M. Nishimura, A. Distenfeld, R. D. Levere, and N. G. Abraham. 1992. Specificity of heme for hemopoietic recovery from AZT toxicity. Hematol. Pathol. 6:79-85.
23. Mathews, J. L., J. T. Newman, F. Sogandares-Bernal, M. M. Judy, H. Skiles, J. E. Leveson, A. J. Marengo-Rowe, and T. C. Chanh. 1988. Photodynamic therapy of viral contaminants with potential for blood banking applications. Transfusion 28:81-83.
24. Monette, F. C., and A. S. Holden. 1982 Hemin enhances the in vitro growth of primitive erythroid progenitor cells. Blood 60:527-530
25. Monette, F. C., S. A. Holden, M. J. Sheehy, and E. A. Matzinger. 1984. Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation. Exp Hematol 12:782-787.
26. Pluda, J. M., H. Mitsuya, and R. Yarchoan. 1991. Hematologic effects of AIDS therapies. Hematol. Oncol. Aspects HIV Dis. 5:229-248.
27. Richman, D. D., M. A. Fischl, M. H. Grieco, M. S. Gottlieb, P. A. Bolberding, O. L. Laskin, J. M. Leedom, J. E. Groopmen, D. Mildvan, M. S. Hirsch, G. G. Jackson, D. T. Durack, S. Musinoff-Lehrman, and the AZT Collaborative Working Group. 1987. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J Med. 317:192-197.
28. Sommadossi, J. P. 1993. Nucleuside analogs: similarities and differences Clin. Infect. Dis. 16(Suppl. 1):S7-S15.
29. Sommadossi, J. P., and R. Carlisle. 1987. Toxicity of 3′-azido-3′-deoxythymidine and 9-(1.3-dihydroxy-2-propoxymethyl)guaninc for normal human hematopoictic progenitor cells in vitro Antimicrob Agents Chemother. 31:452-454.
30. Sommadossi, J. P., R. Carlisle, R. F. Schinazi, and Z. Zhou. 1988. Uridine reverses the toxicity of 3′-azido-3′-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity. Antimiciob. Agents Chemother 32:997-1001.
31. Sommadossi, J. P., R. F. Schinazi, C. K. Chu, and M. Y. Xie. 1902. Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2′.3′-dideoxy-3′-thiacytidine in normal human hone marrow progenitor cells Biochem Pharmacol. 44:1921-1925.
32. Sommadossi, J. P., Z. Zhou, R. Carlisle, M. Y. Xie, D. A. Weidner, and M. H. el Kouni. 1990. Novel pharmacologic approaches to the treatment of AIDS and potential use of uridine phosphorylase inhibitors. p. 63-73. In R B Diasio and J P Sommadossi (ed.), Advances in chemotherapy of AIDS Pergamon Press, New York.
33. Spour, E. F., J. E. Brandt, R. A. Briddell, T. Leemhuis, K. V. Besien, and R. Hoffman. 1991. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells 17:287-295.
34. Stagg, M. P., E. M. Cretton, L. Kidd, R. B. Diasio, and J. P. Sommadossi. 1992. Clinical pharmacokinetics of 3′-azido-3′-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3′-amino-3′-deoxythymidine. Clin. Pharmacol. Ther. 51:668-676.
35. Weidner, D. A., E. G. Bridges, E. M. Cretton, and J. P. Sommadossi. 1992. Comparative effects of 3′-azido-3′-deoxythymidine and its metabolite, 3′-amino-3′-deoxythymidine, on hemoglobin synthesis in K-562 human leukemia cells Mol. Pharmacol. 41:252-258.
36. Weidner, D. A., and J. P. Sommadossi, 1990. 3′-Azido-3′-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells. Mol. Pharmacol 38:797-804.